JFGIW
AGIO icon

Johnson Financial Group Inc (Wisconsin)’s Agios Pharmaceuticals AGIO Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-60
Closed -$2.06K – 851
2024
Q4 		$2.06K Sell
60
-16
-21% -$752 ﹤0.01% 802
2024
Q3 		$3.38K Buy
+76
New +$3.45K ﹤0.01% 830

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s AGIO Position: Q1 2025 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Agios Pharmaceuticals (AGIO) in Q1 2025, closing a stake of 60 shares — an estimated $2.06K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in AGIO in Q3 2024 and held it in 2 quarters. The position peaked at $3.38K in Q3 2024. 220 funds tracked by Wall St. Rank hold AGIO as of Q1 2025.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Agios Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 60 Agios Pharmaceuticals shares in Q1 2025, an estimated $2.06K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Agios Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Agios Pharmaceuticals position peaked at $3.38K in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2025.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2025, filed 15 May 2025.